BioNexus Gene Lab (BGLC) Other Accumulated Expenses (2019 - 2026)

BioNexus Gene Lab's Other Accumulated Expenses history runs 8 years deep, the most recent figure standing at $58251.0 for Q1 2026.

• In Q1 2026, Other Accumulated Expenses rose 11.65% year-over-year to $58251.0; the TTM figure through Mar 2026 stood at $58251.0 (up 11.65% YoY), while the FY2025 annual figure was $59147.0, up 16.39% from the prior year.
• Other Accumulated Expenses came in at $58251.0 for Q1 2026 at BioNexus Gene Lab, down from $59147.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $59147.0 in Q4 2025 to a low of $11782.0 in Q3 2022.
• A 5-year average of $36887.5 and a median of $34632.0 in 2023 frame the typical range for Other Accumulated Expenses.
• Across the five-year window, Other Accumulated Expenses plunged 36.54% in 2022 and soared 230.54% in 2024, its largest moves.
• BioNexus Gene Lab's Other Accumulated Expenses stood at $16569.0 in 2022, then surged by 109.02% to $34632.0 in 2023, then jumped by 46.73% to $50816.0 in 2024, then grew by 16.39% to $59147.0 in 2025, then decreased by 1.51% to $58251.0 in 2026.
• According to Business Quant data, Other Accumulated Expenses over the past three periods registered $58251.0, $59147.0, and $56803.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison